Comparative Pharmacology
Head-to-head clinical analysis: GILDESS 24 FE versus N E E 1 35 21.
Peer-Reviewed Evidence
Head-to-head clinical analysis: GILDESS 24 FE versus N E E 1 35 21.
GILDESS 24 FE vs N.E.E. 1/35 21
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Combination of ethinyl estradiol and drospirenone provides contraceptive effect primarily by suppression of gonadotropins (FSH and LH), inhibition of ovulation, and alterations in cervical mucus and endometrium. Drospirenone has antimineralocorticoid activity and antiandrogenic properties.
Combination estrogen-progestin contraceptive: ethinyl estradiol (estrogen) and norethindrone (progestin). Suppresses gonadotropin (FSH, LH) release via negative feedback, inhibiting ovulation; increases cervical mucus viscosity to impede sperm penetration; alters endometrial development to reduce implantation likelihood.
One tablet orally once daily for 24 days, followed by 4 days of placebo (iron tablets). The active tablets contain 0.8 mg norethindrone acetate and 0.025 mg ethinyl estradiol.
One tablet orally once daily for 21 days, followed by 7 days off.
None Documented
None Documented
Ethinyl estradiol: terminal half-life ~13-27 hours (mean ~17 hours); drospirenone: terminal half-life ~30-40 hours (mean ~32 hours). Clinical context: Steady-state achieved within 10 days for both components.
Norethindrone: terminal half-life 7-8 hours; Ethinyl estradiol: terminal half-life 12-14 hours (with enterohepatic recycling). Clinically, steady state achieved after 5-7 days.
Renal: ~50-60% as metabolites (ethinyl estradiol glucuronide and sulfate conjugates, drospirenone metabolites); fecal: ~40-50% (drospirenone metabolites); biliary excretion contributes to enterohepatic circulation.
Norethindrone (NET) and ethinyl estradiol (EE) are excreted primarily in urine (~50-60% as metabolites) and feces (~30-40% as metabolites); less than 1% excreted unchanged.
Category C
Category C
Oral Contraceptive
Oral Contraceptive